StemRIM (TYO:4599)
177.00
-3.00 (-1.67%)
Sep 16, 2026, 3:30 PM JST
StemRIM Employees
StemRIM had 45 employees as of July 31, 2025. The number of employees increased by 1 or 2.27% compared to the previous year.
Employees
45
Change (1Y)
1
Growth (1Y)
2.27%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
11.28B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jul 31, 2025 | 45 | 1 | 2.27% |
| Jul 31, 2024 | 44 | -1 | -2.22% |
| Jul 31, 2023 | 45 | 1 | 2.27% |
| Jul 31, 2022 | 44 | -2 | -4.35% |
| Jul 31, 2021 | 46 | 12 | 35.29% |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ReproCELL | 101 |
| RaQualia Pharma | 85 |
| Carna Biosciences | 61 |
| AnGes | 56 |
| Immuno-Biological Laboratories | 54 |
| OncoTherapy Science | 46 |
| Nano Holdings | 23 |
| K Pharma,Inc. | 20 |